CYCLERION THERAPEUTICS INC (CYCN)
US23255M2044 - Common Stock
| 2023 (2023-12-31) | 2022 (2022-12-31) | 2021 (2021-12-31) | 2020 (2020-12-31) | 2019 (2019-12-31) | ||||
|---|---|---|---|---|---|---|---|---|
| ASSETS | ||||||||
| Current Assets | ||||||||
| Cash Equivalents | 7.57M | 13.40M | 54.00M | 54.40M | 94.90M | |||
| Receivables | 0.00 | 100.00K | 100.00K | 100.00K | 1.50M | |||
| Other Current Assets | 453.00K | 1.30M | 1.40M | 4.00M | 4.90M | |||
| Total Current Assets | 8.02M | 14.80M | 55.50M | 58.50M | 101.20M | |||
| Non-Current Assets | ||||||||
| PPE Net | 0.00 | 1.20M | 1.50M | 50.30M | 79.80M | |||
| Investments And Advances | 5.35M | N/A | N/A | N/A | N/A | |||
| Other Non-Current Assets | 0.00 | 2.00M | 2.40M | 6.60M | 5.50M | |||
| Total Non-Current Assets | 5.35M | 3.30M | 3.80M | 56.90M | 85.30M | |||
| TOTAL ASSETS | 13.37M | 18.10M | 59.30M | 115.40M | 186.50M | |||
| LIABILITIES | ||||||||
| Current Liabilities | ||||||||
| Short Term Debt | 0.00 | 0.00 | 0.00 | 3.50M | 0.00 | |||
| Accrued Expenses | 786.00K | 4.60M | 8.80M | 11.80M | 14.50M | |||
| Accounts Payable | 1.20M | 3.00M | 1.80M | 1.40M | 3.30M | |||
| Other Current Liabilities | 102.00K | 100.00K | 500.00K | 200.00K | 400.00K | |||
| Total Current Liabilities | 2.09M | 7.60M | 11.10M | 17.00M | 18.20M | |||
| Non-Current Liabilities | ||||||||
| Long Term Debt | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |||
| Other Non-Current Liabilities | 0.00 | 0.00 | 0.00 | 38.90M | 70.50M | |||
| Total Non-Current Liabilities | 0.00 | 0.00 | 0.00 | 38.90M | 70.50M | |||
| TOTAL LIABILITIES | 2.09M | 7.60M | 11.10M | 55.90M | 88.70M | |||
| SHAREHOLDERS' EQUITY | ||||||||
| Retained Earnings | -264.42M | -259.20M | -215.10M | -163.40M | -85.60M | |||
| Additional Paid In Capital | 275.72M | 269.60M | 263.30M | 222.90M | 183.40M | |||
| Common Shares | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |||
| Other Shareholders' Equity | -12.00K | 0.00 | 0.00 | 0.00 | 0.00 | |||
| Shares Outstanding | 2.47M | 2.20M | 2.20M | 1.70M | 1.40M | |||
| Tangible Book Value per Share | 4.56 | 4.77 | 21.91 | 35.00 | 69.79 | |||
| Total Shareholders' Equity | 11.29M | 10.50M | 48.20M | 59.50M | 97.70M | |||
| TOTAL LIABILITIES AND EQUITY | 13.37M | 18.10M | 59.30M | 115.40M | 186.50M | |||
| Statistics | ||||||||
| Current Ratio | 3.85 | 1.95 | 5.00 | 3.44 | 5.56 | |||
| Return On Assets (ROA) | -39.35% | -243.54% | -87.10% | -67.42% | -65.96% | |||
| Return On Equity (ROE) | -46.62% | -419.81% | -107.16% | -130.76% | -125.91% | |||
All data in USD